HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

REACH Information Requirements Have Changed; ECHA Preparing Guidance

Executive Summary

The European Chemicals Agency is targeting the back half of 2022 for guidance on revised information requirements for substances registered under REACH, following a European Commission regulation published in March.

You may also be interested in...



ECHA Reviewing Discounted REACH Fees To Ensure SMEs Truly Qualify

The European Chemicals Agency will be asking companies that benefited from reduced fees on REACH registrations during the 2013-2015 period to provide documentation verifying their SME status. Registrants need to be checking REACH-IT regularly and potentially taking proactive measures to avoid penalties.

L’Oreal Paris League Of Experts; ELC Names Tom Ford Leaders; Every Man Jack Gets B Corp Certified; Cosmetics News

“Establishing a collective will allow us to better reach and engage with our consumers in a way that feels approachable and relatable,” says L’Oreal Paris US, which has brought on prominent makeup artists Allan Avendaño, Claudia Betancur, and Erica Taylor as the first members of its League of Experts. More cosmetics news.

Inter Parfums Expects ‘Another Spectacular Year’ As Prestige Fragrance Boom Continues

The New York-based firm recorded 24% growth in fiscal 2023 first-quarter net sales to $311.7m. The performance reflects growth across all regions as consumers continue to splurge on more expensive fragrances in larger sizes, a trend that arose at the height of the global pandemic.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152510

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel